Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of neoadjuvant chemohormonal therapy for high-risk prostate cancer treated with robot-assisted laparoscopic radical prostatectomy: a propensity score-matched analysis (the MSUG94 group).
Yokoyama Y, Kawase M, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, Nakayama A, Toide M, Yoneda T, Sakaguchi K, Teishima J, Makiyama K, Inoue T, Kitamura H, Saito K, Koga F, Urakami S, Koie T. Yokoyama Y, et al. Among authors: toide m. Int Urol Nephrol. 2024 Nov 8. doi: 10.1007/s11255-024-04268-2. Online ahead of print. Int Urol Nephrol. 2024. PMID: 39516348
Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastases.
Yoshida S, Maezawa Y, Ishihara K, Inoue N, Tanabe K, Izumi K, Fujiwara M, Toide M, Yamamoto T, Uehara S, Araki S, Inoue M, Takazawa R, Numao N, Ohtsuka Y, Tanaka H, Fujii Y. Yoshida S, et al. Among authors: toide m. Int J Urol. 2024 Nov;31(11):1234-1240. doi: 10.1111/iju.15542. Epub 2024 Jul 15. Int J Urol. 2024. PMID: 39010666
Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study.
Tanabe K, Kobayashi S, Maezawa Y, Ishihara K, Inoue N, Izumi K, Fujiwara M, Toide M, Yamamoto T, Uehara S, Araki S, Inoue M, Takazawa R, Numao N, Ohtsuka Y, Tanaka H, Yoshida S, Fujii Y. Tanabe K, et al. Among authors: toide m. Int J Clin Oncol. 2024 Sep;29(9):1302-1310. doi: 10.1007/s10147-024-02563-7. Epub 2024 Jun 4. Int J Clin Oncol. 2024. PMID: 38833113
Prognostic factors among patients with pathological Grade Group 5 prostate cancer based on robot-associated radical prostatectomy specimens from a large Japanese cohort (MSUG94).
Sasaki T, Ebara S, Tatenuma T, Ikehata Y, Nakayama A, Kawase M, Toide M, Yoneda T, Sakaguchi K, Teishima J, Makiyama K, Kitamura H, Saito K, Koie T, Koga F, Urakami S, Inoue T. Sasaki T, et al. Among authors: toide m. World J Urol. 2024 Mar 14;42(1):152. doi: 10.1007/s00345-024-04864-y. World J Urol. 2024. PMID: 38483586
Prognostic Importance of Lymphovascular Invasion for Specific Subgroup of Patients with Prostate Cancer After Robot-Assisted Radical Prostatectomy (The MSUG94 Group).
Kawase M, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, Nakayama A, Toide M, Yoneda T, Sakaguchi K, Teishima J, Makiyama K, Inoue T, Kitamura H, Saito K, Koga F, Urakami S, Koie T. Kawase M, et al. Among authors: toide m. Ann Surg Oncol. 2024 Mar;31(3):2154-2162. doi: 10.1245/s10434-023-14691-x. Epub 2024 Jan 10. Ann Surg Oncol. 2024. PMID: 38200385
The Negative Impact of Inflammation-Related Parameters in Prostate Cancer after Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (the MSUG94 Group).
Murase K, Kawase M, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, Nakayama A, Toide M, Yoneda T, Sakaguchi K, Teishima J, Makiyama K, Inoue T, Kitamura H, Saito K, Koga F, Urakami S, Koie T. Murase K, et al. Among authors: toide m. J Clin Med. 2023 Dec 17;12(24):7732. doi: 10.3390/jcm12247732. J Clin Med. 2023. PMID: 38137801 Free PMC article.
Early and late urinary continence outcomes after unilateral and bilateral nerve-sparing robot-assisted radical prostatectomy: A retrospective multicentre cohort study in Japan (the MSUG94 group).
Sakaguchi K, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, Nakayama A, Kawase M, Toide M, Yoneda T, Teishima J, Makiyama K, Inoue T, Kitamura H, Saito K, Koie T, Koga F, Urakami S. Sakaguchi K, et al. Among authors: toide m. Int J Med Robot. 2023 Nov 20:e2593. doi: 10.1002/rcs.2593. Online ahead of print. Int J Med Robot. 2023. PMID: 37984071
30 results